Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double-Blind, Placebo Controlled Study To Compare Efficacy and Safety of Trifarotene (CD5789) Cream When Used Withan Oral Antibiotic for the Treatment of Severe Acne Vulgaris
Conditions
Interventions
Trifarotene cream
Doxycycline hyclate
+2 more
Locations
26
United States
Galderma Investigational Site
Fort Smith, Arkansas, United States
Galderma Investigational Site
Hot Springs, Arkansas, United States
Galderma Investigational Site
Rogers, Arkansas, United States
Galderma Investigational Site
Newport Beach, California, United States
Galderma Investigational Site
Aventura, Florida, United States
Galderma Investigational Site
Boca Raton, Florida, United States
Start Date
July 29, 2020
Primary Completion Date
April 26, 2021
Completion Date
April 26, 2021
Last Updated
May 10, 2022
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT06415305
Lead Sponsor
Galderma R&D
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions